Latest News about biotech
Recent news which mentions biotech
BioAge seeks nearly $200 million in initial public offering
September 27, 2024
From Business Journals
TBJ Fast 50 2024: No. 27 – Core Technology Molding Corp.
September 26, 2024
From Business Journals
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
September 26, 2024
From Benzinga
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
September 26, 2024
From Benzinga
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
September 26, 2024
From Benzinga
Evaxion Biotech Partners With Merck To Expand Vaccine Development
September 26, 2024
From Benzinga
Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
September 26, 2024
From Benzinga
Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development
September 26, 2024
From Benzinga
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths
September 26, 2024
From Benzinga
Why Is Pasithea Therapeutics Stock Surging On Thursday?
September 26, 2024
From Benzinga
EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
September 26, 2024
From Benzinga
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
September 25, 2024
Tickers
LLY
From Benzinga
LIFD's 5x Potential: Is This Psychoactive Hemp Stock The Next Big Speculative Buy?
September 25, 2024
From Benzinga
Telesis Bio Stock Is Soaring Wednesday: What's Going On?
September 25, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.